Abstract:Epilepsy Currents, Ahead of Print. Cardiac-Specific Deletion of Scn8a Mitigates Dravet Syndrome-Associated Sudden Death in AdultsKing DR, Demirtas M, Tarasov M, Struckman HL, Meng X, Nassal D, Moise N, Miller A, Min D, Soltisz AM, Anne MNK, Alves DPA, Wagnon JL, Weinberg SH, Hund TJ, Veeraraghavan R, Radwański PB. JACC Clin. Electrophysiol. 2024;10(5):829–842. doi:10.1016/j.jacep.2024.01.003.Sudden unexpected death in epilepsy (SUDEP) is a fatal complication experienced by otherwise healthy epilepsy patients. Dravet syndrome (DS) is an inherited epileptic disorder resulting from loss-of-function of the voltage-gated sodium channel, NaV 1.1, and is associated with particularly high SUDEP risk. Evidence is mounting that NaVs abundant in the brain also occur in the heart, suggesting that the very molecular mechanisms underlying epilepsy could also precipitate cardiac arrhythmias and sudden death. Despite marked reduction of NaV 1.1 functional expression in DS, pathogenic late sodium current (INa,L) is paradoxically increased in DS hearts. However, the mechanisms by which DS directly impacts the heart to promote sudden death remain unclear. In this study, the authors sought to provide evidence implicating remodeling of Na+- and Ca2+-handling machinery, including NaV 1.6 and Na+/Ca2+ exchanger (NCX) within transverse (T)-tubules in DS-associated arrhythmias. The authors undertook scanning ion conductance microscopy (SICM)-guided patch clamp, super-resolution microscopy, confocal Ca2+ imaging, and in vivo electrocardiography studies in Scn1a haploinsufficient murine model of DS. DS promotes INa,L in T-tubular nanodomains, but not in other subcellular regions. Consistent with increased NaV activity in these regions, super-resolution microscopy revealed increased NaV 1.6 density near Ca2+ release channels, the ryanodine receptors (RyR2), and NCX in DS relative to WT hearts. The resulting INa,L in these regions promoted aberrant Ca2+ release, leading to ventricular arrhythmias in vivo. Cardiac-specific deletion of NaV 1.6 protects adult DS mice from increased T-tubular late NaV activity and the resulting arrhythmias, as well as sudden death. These data demonstrate that NaV 1.6 undergoes remodeling within T-tubules of adult DS hearts serving as a substrate for Ca2+-mediated cardiac arrhythmias and may be a druggable target for the prevention of SUDEP in adult DS subjects. Molecular and Cellular Context Influences SCN8A Variant FunctionVanoye CG, Abramova TV, DeKeyser J-M, Ghabra NF, Oudin MJ, Burge CB, Helbig I, Thompson CH, George AL. JCI Insight 2024; 9(12). doi:10.1172/jci.insight.177530.Pathogenic variants in SCN8A, which encodes the voltage-gated sodium (NaV) channel NaV1.6, associate with neurodevelopmental disorders, including developmental and epileptic encephalopathy. Previous approaches to determine SCN8A variant function may be confounded by use of a neonatally expressed, alternatively spliced isoform of NaV1.6 (NaV1.6N) and engineered mutations rendering the channel tetrodotoxin (TTX) resistant. We investigated the impact of SCN8A alternative splicing on variant function by comparing the functional attributes of 15 variants expressed in 2 developmentally regulated splice isoforms (NaV1.6N, NaV1.6A). We employed automated patch clamp recording to enhance throughput and developed a neuronal cell line (ND7/LoNav) with low levels of endogenous NaV current to obviate the need for TTX-resistance mutations. Expression of NaV1.6N or NaV1.6A in ND7/LoNav cells generated NaV currents with small, but significant, differences in voltage dependence of activation and inactivation. TTX-resistant versions of both isoforms exhibited significant functional differences compared with the corresponding WT channels. We demonstrated that many of the 15 disease-associated variants studied exhibited isoform-dependent functional effects and that many of the studied SCN8A variants exhibited functional properties that were not easily classified as either gain- or loss-of-function. Our work illustrates the value of considering molecular and cellular context when investigating SCN8A variants.

Allele‐Specific Editing of a Dominant SCN8A Epilepsy Variant Protects against Seizures and Lethality in a Murine Model

Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome

Variant‐specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy

A novel mouse model for developmental and epileptic encephalopathy by Purkinje cell-specific deletion of Scn1b

Antisense oligonucleotide therapy for KCNT1 encephalopathy

A SCN8A variant associated with severe early onset epilepsy and developmental delay: Loss- or gain-of-function?

Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy

Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice

Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human Ipscs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.

Exogenous Nav1.1 activity in excitatory and inhibitory neurons reverts Dravet syndrome comorbidities when delivered post-symptom onset in mice with Dravet

Parvalbumin interneuron impairment causes synaptic transmission deficits and seizures in SCN8A developmental and epileptic encephalopathy

Impaired excitability of fast-spiking neurons in a novel mouse model of epileptic encephalopathy

Electrophysiological Features: the Next Precise Step for SCN2A Developmental Epileptic Encephalopathy

Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome

Rapid modeling of an ultra-rare epilepsy patient variant in mice by in utero prime editing

Impaired excitability of fast-spiking neurons in a novel mouse model of KCNC1 epileptic encephalopathy

SCN1A intronic variants impact on Nav1.1 protein expression and sodium channel function, and associated with epilepsy phenotypic severity

Revoking the Seize Order: Preventing Spontaneous Seizures With AAV in a CLN2 Mouse Model

Salty Battle to Sudden Death: Young vs. Old, Brain vs. Heart

Targeting heterozygous dominant negative variant of KCNA2 using Gapmer antisense oligonucleotides (ASO) for the treatment of drug-resistant epilepsy

In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice